News Posts List
Aerobics, Strength Exercises Improve Quality of Life in Kidney Cancer Survivors
02/12/2019
Meeting combined exercise guidelines – including both aerobics and strength training – improved quality of life in #KidneyCancer survivors; however, few individuals reported they follow such guidelines, according to study findings published in Psycho-Oncology.
Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer
02/08/2019
Nephron-sparing surgery (NSS) remains gold standard for the treatment of localised renal cell cancer (RCC), even in the case of a normal contralateral kidney.
Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: A retrospective single-center study
02/06/2019
Renal cell carcinoma (RCC) is typically found in the older age group between 50 and 70 years of age. However, diagnosis of renal cancer is increasing more rapidly in patients less than 40 years if age compared to older age patients.
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study
02/06/2019
Targeted therapy (TT) has improved survival for metastatic renal cell carcinoma (mRCC). However, survival is usually limited if brain metastases (BMs) develop.
If Someone in Your Life Just Survived Cancer, Here’s How You Can Support Them Now
02/05/2019
This article explains how to support a loved one after cancer treatment.
Some Cancers Are Rising in Millennials. Obesity Might Be Why
02/04/2019
Kidney cancer had the sharpest annual increase for young Americans: 6.23% between 1995 and 2014.
Newsmakers: Promotions and appointments of area executives
02/04/2019
Gretchen Vaughan, Kidney Cancer Association, has been named chief executive officer of the nonprofit.
First-Line TKIs Less Effective in Non-Clear-Cell Renal Cell Carcinoma
01/31/2019
According to a study that was published in Urologic Oncology, patients with metastatic non-clear-cell renal cell carcinoma (nccRCC) have worse outcomes from first-line therapy with tyrosine kinase inhibitors (TKIs) than patients with metastatic clear-cell RCC (ccRCC).
Personalized Vaccine to be Tested in Patients with Kidney Cancer
01/30/2019
Researchers at the Dana-Farber Cancer Institute are working to develop a vaccine for the treatment of renal cell cancer.
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
01/29/2019
This study evaluates whether sunitinib and pazopanib treatments are associated with change in skeletal muscle area (SMA) and total lean body mass (LBM) as well as to compare their efficacies and safety profiles in patients with metastatic renal cell cancer (mRCC).
News Feed